Dr. Joshua A. Beckman is an Associate Professor of Medicine at Harvard Medical School and Director of the Cardiovascular Fellowship Program at Brigham and Women’s Hospital, both in Boston, Massachusetts. After earning his medical degree from New York University School of Medicine in New York City, he completed an internship, residency, and chief residency in Internal Medicine at Columbia Presbyterian Medical Center and a postgraduate fellowship in Cardiovascular Medicine and Vascular Medicine at Brigham and Women’s Hospital. He is President of the Society of Vascular Medicine and Biology and is active in numerous other professional organizations, including the American College of Cardiology and the American Heart Association. Dr. Beckman is the recipient of the Daniel D. Federman Outstanding Clinical Educator award at Harvard Medical School, the W. Proctor Harvey Young Teacher Award from American College of Cardiology, as well as the inaugural Eugene Braunwald Teaching Award from Brigham and Women’s Hospital.

Dr. Beckman’s primary research interests lie in understanding the mechanisms of human vascular endothelium function and dysfunction.  He has active investigations on the impact to vascular homeostasis from the metabolic disturbances in diabetes, changes in endothelial growth factors, and the impact of chronic inflammatory diseases. His findings have been published in more than two dozen articles in peer-reviewed journals, including Circulation, Circulation Research, and JACC, and he has authored or coauthored chapters in more than a dozen textbooks.

 

Selected Publications:

Owens CD, Wake, N, Conte, MS, Gerhard-Herman, M, Beckman, JA. In Vivo Human Lower Extremity Saphenous Vein Bypass Grafts Manifest Flow Mediated Vasodilation. Journal of Vascular Surgery. 2009;50(5):1063-70.

Beckman JA, Goldfine AB, Goldin A, Prsic A, Kim S, Creager MA. Inhibition of Protein Kinase C ß does not improve endothelial function in type 2 diabetes. J Clin Endocrinol Metab. 2010;95:3783-7.

Sobieszczyk P, Borlaug BA, Gornik HL, Knauft WD, Beckman JA.  Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans. Clinical Science. 2010;119:437–42

Mayer EL, Dallabrida SM, Rupnick MA, Redline WM, Hannagan K, IsmailNS, Burstein HJ, Beckman JA. Contrary effects of the RTK inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans. Hypertension. 2011; 58(1):85-92.

Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK.  Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA. 2011; 306(21):2359-66.

 

For a complete list of Dr. Joshua Beckman’s publications, click here.